Global Irritable Bowel Syndrome (IBS) Market Size, Status and Forecast 2023

Report ID: 1234721 | Published Date: Jan 2025 | No. of Page: 96 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 IBS-D Drug
        1.2.3 IBS-C Drug
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Irritable Bowel Syndrome (IBS) Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Women
        1.3.3 Men
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Irritable Bowel Syndrome (IBS) Market Perspective (2016-2027)
    2.2 Irritable Bowel Syndrome (IBS) Growth Trends by Regions
        2.2.1 Irritable Bowel Syndrome (IBS) Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Irritable Bowel Syndrome (IBS) Historic Market Share by Regions (2016-2021)
        2.2.3 Irritable Bowel Syndrome (IBS) Forecasted Market Size by Regions (2022-2027)
    2.3 Irritable Bowel Syndrome (IBS) Industry Dynamic
        2.3.1 Irritable Bowel Syndrome (IBS) Market Trends
        2.3.2 Irritable Bowel Syndrome (IBS) Market Drivers
        2.3.3 Irritable Bowel Syndrome (IBS) Market Challenges
        2.3.4 Irritable Bowel Syndrome (IBS) Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Irritable Bowel Syndrome (IBS) Players by Revenue
        3.1.1 Global Top Irritable Bowel Syndrome (IBS) Players by Revenue (2016-2021)
        3.1.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players (2016-2021)
    3.2 Global Irritable Bowel Syndrome (IBS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Irritable Bowel Syndrome (IBS) Revenue
    3.4 Global Irritable Bowel Syndrome (IBS) Market Concentration Ratio
        3.4.1 Global Irritable Bowel Syndrome (IBS) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Irritable Bowel Syndrome (IBS) Revenue in 2020
    3.5 Irritable Bowel Syndrome (IBS) Key Players Head office and Area Served
    3.6 Key Players Irritable Bowel Syndrome (IBS) Product Solution and Service
    3.7 Date of Enter into Irritable Bowel Syndrome (IBS) Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Irritable Bowel Syndrome (IBS) Breakdown Data by Type
    4.1 Global Irritable Bowel Syndrome (IBS) Historic Market Size by Type (2016-2021)
    4.2 Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Type (2022-2027)

5 Irritable Bowel Syndrome (IBS) Breakdown Data by Application
    5.1 Global Irritable Bowel Syndrome (IBS) Historic Market Size by Application (2016-2021)
    5.2 Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Irritable Bowel Syndrome (IBS) Market Size (2016-2027)
    6.2 North America Irritable Bowel Syndrome (IBS) Market Size by Type
        6.2.1 North America Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021)
        6.2.2 North America Irritable Bowel Syndrome (IBS) Market Size by Type (2022-2027)
        6.2.3 North America Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2027)
    6.3 North America Irritable Bowel Syndrome (IBS) Market Size by Application
        6.3.1 North America Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021)
        6.3.2 North America Irritable Bowel Syndrome (IBS) Market Size by Application (2022-2027)
        6.3.3 North America Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2027)
    6.4 North America Irritable Bowel Syndrome (IBS) Market Size by Country
        6.4.1 North America Irritable Bowel Syndrome (IBS) Market Size by Country (2016-2021)
        6.4.2 North America Irritable Bowel Syndrome (IBS) Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Irritable Bowel Syndrome (IBS) Market Size (2016-2027)
    7.2 Europe Irritable Bowel Syndrome (IBS) Market Size by Type
        7.2.1 Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021)
        7.2.2 Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2022-2027)
        7.2.3 Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2027)
    7.3 Europe Irritable Bowel Syndrome (IBS) Market Size by Application
        7.3.1 Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021)
        7.3.2 Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2022-2027)
        7.3.3 Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2027)
    7.4 Europe Irritable Bowel Syndrome (IBS) Market Size by Country
        7.4.1 Europe Irritable Bowel Syndrome (IBS) Market Size by Country (2016-2021)
        7.4.2 Europe Irritable Bowel Syndrome (IBS) Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size (2016-2027)
    8.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Type
        8.2.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2027)
    8.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Application
        8.3.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2027)
    8.4 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Region
        8.4.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Irritable Bowel Syndrome (IBS) Market Size (2016-2027)
    9.2 Latin America Irritable Bowel Syndrome (IBS) Market Size by Type
        9.2.1 Latin America Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021)
        9.2.2 Latin America Irritable Bowel Syndrome (IBS) Market Size by Type (2022-2027)
        9.2.3 Latin America Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2027)
    9.3 Latin America Irritable Bowel Syndrome (IBS) Market Size by Application
        9.3.1 Latin America Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021)
        9.3.2 Latin America Irritable Bowel Syndrome (IBS) Market Size by Application (2022-2027)
        9.3.3 Latin America Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2027)
    9.4 Latin America Irritable Bowel Syndrome (IBS) Market Size by Country
        9.4.1 Latin America Irritable Bowel Syndrome (IBS) Market Size by Country (2016-2021)
        9.4.2 Latin America Irritable Bowel Syndrome (IBS) Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size (2016-2027)
    10.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Type
        10.2.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2027)
    10.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Application
        10.3.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2027)
    10.4 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country
        10.4.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Bausch Health
        11.1.1 Bausch Health Company Details
        11.1.2 Bausch Health Business Overview
        11.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Introduction
        11.1.4 Bausch Health Revenue in Irritable Bowel Syndrome (IBS) Business (2016-2021)
        11.1.5 Bausch Health Recent Development
    11.2 Allergan
        11.2.1 Allergan Company Details
        11.2.2 Allergan Business Overview
        11.2.3 Allergan Irritable Bowel Syndrome (IBS) Introduction
        11.2.4 Allergan Revenue in Irritable Bowel Syndrome (IBS) Business (2016-2021)
        11.2.5 Allergan Recent Development
    11.3 Takeda
        11.3.1 Takeda Company Details
        11.3.2 Takeda Business Overview
        11.3.3 Takeda Irritable Bowel Syndrome (IBS) Introduction
        11.3.4 Takeda Revenue in Irritable Bowel Syndrome (IBS) Business (2016-2021)
        11.3.5 Takeda Recent Development
    11.4 Sucampo Pharmaceuticals (Mallinckrodt)
        11.4.1 Sucampo Pharmaceuticals (Mallinckrodt) Company Details
        11.4.2 Sucampo Pharmaceuticals (Mallinckrodt) Business Overview
        11.4.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Introduction
        11.4.4 Sucampo Pharmaceuticals (Mallinckrodt) Revenue in Irritable Bowel Syndrome (IBS) Business (2016-2021)
        11.4.5 Sucampo Pharmaceuticals (Mallinckrodt) Recent Development
    11.5 Sebela Pharmaceuticals Inc
        11.5.1 Sebela Pharmaceuticals Inc Company Details
        11.5.2 Sebela Pharmaceuticals Inc Business Overview
        11.5.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Introduction
        11.5.4 Sebela Pharmaceuticals Inc Revenue in Irritable Bowel Syndrome (IBS) Business (2016-2021)
        11.5.5 Sebela Pharmaceuticals Inc Recent Development
    11.6 Astellas Pharmaceuticals
        11.6.1 Astellas Pharmaceuticals Company Details
        11.6.2 Astellas Pharmaceuticals Business Overview
        11.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Introduction
        11.6.4 Astellas Pharmaceuticals Revenue in Irritable Bowel Syndrome (IBS) Business (2016-2021)
        11.6.5 Astellas Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of IBS-D Drug
    Table 3. Key Players of IBS-C Drug
    Table 4. Key Players of Others
    Table 5. Global Irritable Bowel Syndrome (IBS) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Irritable Bowel Syndrome (IBS) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Irritable Bowel Syndrome (IBS) Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Irritable Bowel Syndrome (IBS) Market Share by Regions (2016-2021)
    Table 9. Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Irritable Bowel Syndrome (IBS) Market Share by Regions (2022-2027)
    Table 11. Irritable Bowel Syndrome (IBS) Market Trends
    Table 12. Irritable Bowel Syndrome (IBS) Market Drivers
    Table 13. Irritable Bowel Syndrome (IBS) Market Challenges
    Table 14. Irritable Bowel Syndrome (IBS) Market Restraints
    Table 15. Global Irritable Bowel Syndrome (IBS) Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Irritable Bowel Syndrome (IBS) Market Share by Players (2016-2021)
    Table 17. Global Top Irritable Bowel Syndrome (IBS) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Irritable Bowel Syndrome (IBS) as of 2020)
    Table 18. Ranking of Global Top Irritable Bowel Syndrome (IBS) Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Irritable Bowel Syndrome (IBS) Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Irritable Bowel Syndrome (IBS) Product Solution and Service
    Table 22. Date of Enter into Irritable Bowel Syndrome (IBS) Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Type (2016-2021)
    Table 26. Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Irritable Bowel Syndrome (IBS) Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Application (2016-2021)
    Table 30. Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Irritable Bowel Syndrome (IBS) Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Irritable Bowel Syndrome (IBS) Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Irritable Bowel Syndrome (IBS) Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Irritable Bowel Syndrome (IBS) Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Irritable Bowel Syndrome (IBS) Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Irritable Bowel Syndrome (IBS) Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Irritable Bowel Syndrome (IBS) Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Irritable Bowel Syndrome (IBS) Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Irritable Bowel Syndrome (IBS) Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Irritable Bowel Syndrome (IBS) Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Bausch Health Company Details
    Table 63. Bausch Health Business Overview
    Table 64. Bausch Health Irritable Bowel Syndrome (IBS) Product
    Table 65. Bausch Health Revenue in Irritable Bowel Syndrome (IBS) Business (2016-2021) & (US$ Million)
    Table 66. Bausch Health Recent Development
    Table 67. Allergan Company Details
    Table 68. Allergan Business Overview
    Table 69. Allergan Irritable Bowel Syndrome (IBS) Product
    Table 70. Allergan Revenue in Irritable Bowel Syndrome (IBS) Business (2016-2021) & (US$ Million)
    Table 71. Allergan Recent Development
    Table 72. Takeda Company Details
    Table 73. Takeda Business Overview
    Table 74. Takeda Irritable Bowel Syndrome (IBS) Product
    Table 75. Takeda Revenue in Irritable Bowel Syndrome (IBS) Business (2016-2021) & (US$ Million)
    Table 76. Takeda Recent Development
    Table 77. Sucampo Pharmaceuticals (Mallinckrodt) Company Details
    Table 78. Sucampo Pharmaceuticals (Mallinckrodt) Business Overview
    Table 79. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product
    Table 80. Sucampo Pharmaceuticals (Mallinckrodt) Revenue in Irritable Bowel Syndrome (IBS) Business (2016-2021) & (US$ Million)
    Table 81. Sucampo Pharmaceuticals (Mallinckrodt) Recent Development
    Table 82. Sebela Pharmaceuticals Inc Company Details
    Table 83. Sebela Pharmaceuticals Inc Business Overview
    Table 84. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product
    Table 85. Sebela Pharmaceuticals Inc Revenue in Irritable Bowel Syndrome (IBS) Business (2016-2021) & (US$ Million)
    Table 86. Sebela Pharmaceuticals Inc Recent Development
    Table 87. Astellas Pharmaceuticals Company Details
    Table 88. Astellas Pharmaceuticals Business Overview
    Table 89. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product
    Table 90. Astellas Pharmaceuticals Revenue in Irritable Bowel Syndrome (IBS) Business (2016-2021) & (US$ Million)
    Table 91. Astellas Pharmaceuticals Recent Development
    Table 92. Research Programs/Design for This Report
    Table 93. Key Data Information from Secondary Sources
    Table 94. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Irritable Bowel Syndrome (IBS) Market Share by Type: 2020 VS 2027
    Figure 2. IBS-D Drug Features
    Figure 3. IBS-C Drug Features
    Figure 4. Others Features
    Figure 5. Global Irritable Bowel Syndrome (IBS) Market Share by Application: 2020 VS 2027
    Figure 6. Women Case Studies
    Figure 7. Men Case Studies
    Figure 8. Irritable Bowel Syndrome (IBS) Report Years Considered
    Figure 9. Global Irritable Bowel Syndrome (IBS) Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Irritable Bowel Syndrome (IBS) Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Irritable Bowel Syndrome (IBS) Market Share by Regions: 2020 VS 2027
    Figure 12. Global Irritable Bowel Syndrome (IBS) Market Share by Regions (2022-2027)
    Figure 13. Global Irritable Bowel Syndrome (IBS) Market Share by Players in 2020
    Figure 14. Global Top Irritable Bowel Syndrome (IBS) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Irritable Bowel Syndrome (IBS) as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Irritable Bowel Syndrome (IBS) Revenue in 2020
    Figure 16. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Type (2016-2021)
    Figure 17. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Type (2022-2027)
    Figure 18. North America Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Irritable Bowel Syndrome (IBS) Market Share by Type (2016-2027)
    Figure 20. North America Irritable Bowel Syndrome (IBS) Market Share by Application (2016-2027)
    Figure 21. North America Irritable Bowel Syndrome (IBS) Market Share by Country (2016-2027)
    Figure 22. United States Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Irritable Bowel Syndrome (IBS) Market Share by Type (2016-2027)
    Figure 26. Europe Irritable Bowel Syndrome (IBS) Market Share by Application (2016-2027)
    Figure 27. Europe Irritable Bowel Syndrome (IBS) Market Share by Country (2016-2027)
    Figure 28. Germany Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Share by Region (2016-2027)
    Figure 38. China Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Irritable Bowel Syndrome (IBS) Market Share by Type (2016-2027)
    Figure 46. Latin America Irritable Bowel Syndrome (IBS) Market Share by Application (2016-2027)
    Figure 47. Latin America Irritable Bowel Syndrome (IBS) Market Share by Country (2016-2027)
    Figure 48. Mexico Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Share by Country (2016-2027)
    Figure 54. Turkey Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Bausch Health Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2016-2021)
    Figure 58. Allergan Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2016-2021)
    Figure 59. Takeda Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2016-2021)
    Figure 60. Sucampo Pharmaceuticals (Mallinckrodt) Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2016-2021)
    Figure 61. Sebela Pharmaceuticals Inc Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2016-2021)
    Figure 62. Astellas Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2016-2021)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bausch Health
Allergan
Takeda
Sucampo Pharmaceuticals (Mallinckrodt)
Sebela Pharmaceuticals Inc
Astellas Pharmaceuticals
Frequently Asked Questions
Irritable Bowel Syndrome (IBS) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Irritable Bowel Syndrome (IBS) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Irritable Bowel Syndrome (IBS) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports